May 3, 2017
A Year After Approval, Gene-Therapy Cure Gets Its First Customer
(Read the full story here / Illustration by Daniel Zender)
seen from Spain
seen from Netherlands
seen from United States
seen from Denmark
seen from Yemen
seen from Belgium
seen from Czechia
seen from United States
seen from Türkiye
seen from Türkiye
seen from United States
seen from China
seen from Armenia
seen from Maldives
seen from United States
seen from Canada
seen from United Kingdom
seen from Germany
seen from United Kingdom
seen from United Kingdom
A Year After Approval, Gene-Therapy Cure Gets Its First Customer
(Read the full story here / Illustration by Daniel Zender)
GlaxoSmithKline Gets Approval Recommendation for Gene Therapy
GlaxoSmithKline Gets Approval Recommendation for Gene Therapy
Recently, Strimvelis received a positive regulatory opinion from EMA’s Committee for Medicinal Products for Human Use (CHMP). Strimvelis is a gene therapy treatment developed by GlaxoSmithKline to treat a rare type of severe combined immunodeficiency (ADA-SCID). If Strimvelis obtains approval, it will be the first gene therapy approved for children in Europe. Before reaching the market, the…
View On WordPress
Selangkah Lagi GSK Luncurkan Terapi Genetik Pertama di Dunia
Selangkah Lagi GSK Luncurkan Terapi Genetik Pertama di Dunia
Selangkah Lagi GSK Luncurkan Terapi Genetik Pertama di Dunia. Perusahaan farmasi terbesar di Inggris GlaxoSmithKline (GSK) telah memenangkan rekomendasi marketing dari regulator Eropa (4/4) untuk terapi gen pertama dalam mengobati kondisi langka yang membuat anak-anak yang baru lahir tidak mampu melawan infeksi sehari-hari.
Terapi yang dikenal sebagai Strimvelis menerima dukungan dari European…
View On WordPress